Cargando…
P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430725/ http://dx.doi.org/10.1097/01.HS9.0000847652.95364.b3 |
| _version_ | 1784779854965637120 |
|---|---|
| author | Strati, P. Leslie, L. Shiraz, P. Budde, E. Oluwole, O. O. Ulrickson, M. Ramakrishnan, A. Sun, J. Shen, R. Kanska, J. McCroskery, P. Dong, J. Schupp, M. Xu, H. Patel, K. |
| author_facet | Strati, P. Leslie, L. Shiraz, P. Budde, E. Oluwole, O. O. Ulrickson, M. Ramakrishnan, A. Sun, J. Shen, R. Kanska, J. McCroskery, P. Dong, J. Schupp, M. Xu, H. Patel, K. |
| author_sort | Strati, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430725 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307252022-08-31 P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY Strati, P. Leslie, L. Shiraz, P. Budde, E. Oluwole, O. O. Ulrickson, M. Ramakrishnan, A. Sun, J. Shen, R. Kanska, J. McCroskery, P. Dong, J. Schupp, M. Xu, H. Patel, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430725/ http://dx.doi.org/10.1097/01.HS9.0000847652.95364.b3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Strati, P. Leslie, L. Shiraz, P. Budde, E. Oluwole, O. O. Ulrickson, M. Ramakrishnan, A. Sun, J. Shen, R. Kanska, J. McCroskery, P. Dong, J. Schupp, M. Xu, H. Patel, K. P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title | P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title_full | P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title_fullStr | P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title_full_unstemmed | P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title_short | P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY |
| title_sort | p1197: axicabtagene ciloleucel (axi-cel) in combination with rituximab for the treatment of relapsed/refractory (r/r) large b-cell lymphoma (lbcl): outcomes of the phase 2 zuma-14 study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430725/ http://dx.doi.org/10.1097/01.HS9.0000847652.95364.b3 |
| work_keys_str_mv | AT stratip p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT lesliel p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT shirazp p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT buddee p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT oluwoleoo p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT ulricksonm p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT ramakrishnana p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT sunj p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT shenr p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT kanskaj p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT mccroskeryp p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT dongj p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT schuppm p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT xuh p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study AT patelk p1197axicabtageneciloleucelaxicelincombinationwithrituximabforthetreatmentofrelapsedrefractoryrrlargebcelllymphomalbcloutcomesofthephase2zuma14study |